Showing results (291-300 of 531) with videos related to

Sort By:
Pageof 54
Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.
Neuroscience Letters|October 24, 1994
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.
Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.
Psychiatry Research|December 1, 1990
Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's diseaseR Rupprecht, L Frölich, T Mergenthaler, et al.
Neuroscience Letters|December 20, 1996
The soluble form of Fas molecule is elevated in parkinsonian brain tissuesM Mogi, M Harada, T Kondo, et al.
European Journal of Pharmacology|July 6, 1993
Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brainJ Deckert, B Bereznai, A Hennemann, et al.
Neuroscience Letters|September 6, 1996
bcl-2 protein is increased in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.
Brain Research|May 29, 1998
Measurement of receptor-mediated functional activation of G proteins in postmortem human brain membranesY Odagaki, N Nishi, H Ozawa, et al.
Chemistry and Physics of Lipids|February 5, 1998
Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brainM Weisser, M Vieth, M Stolte, et al.
Nature Biotechnology|October 3, 1999
Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT libraryG Münch, D Schicktanz, A Behme, et al.
Pageof 54